| In vivo antitumor activity and in vitro cytotoxic properties of bis[1,2-bis(diphenylphosphino)ethane]gold(I) chloride. | |
| | |
MedLine Citation:
|
PMID: 3756897 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
We have previously reported the cytotoxicity and antitumor activity of bis(diphenylphosphino)ethane (DPPE) and a variety of its transition metal complexes. During studies of the chemistry of a gold complex of this group [(AuCl)2(DPPE)], it was observed that this complex readily underwent ring closure on reaction with DPPE to form the tetrahedral complex [Au(DPPE)2]+. Various counterion forms (e.g., Cl-) of this cation were isolated and were found to exhibit a remarkably high stability in solution. Evaluation of [Au(DPPE)2]Cl in mice bearing i.p. P388 leukemia demonstrated that the compound produced an average of 87% increase in life span at its maximally tolerated dose (2-3 mumol/kg/day for 5 days). Activity was also seen in i.p. M5076 reticulum cell sarcoma (60% increase in life span) and s.c. mammary adenocarcinoma 16/c. Modest activity was evident in i.p. B16 melanoma and L1210 leukemia. A subline of P388 leukemia resistant to cisplatin was not cross-resistant to [Au(DPPE)2]Cl. In addition, combination therapy of [Au(DPPE)2]Cl and cisplatin against i.p. P388 demonstrated an advantage over single-agent therapy. In vitro studies of [Au(DPPE)2]Cl showed that the compound: is cytotoxic to tumor cell lines; is only minimally inhibited in its cytotoxic activity by the presence of serum; produces DNA protein cross-links and DNA strand breaks in cells; and inhibits macromolecular synthesis with a preferential inhibitory effect on protein synthesis relative to DNA and RNA synthesis. 31P nuclear magnetic resonance spectroscopy indicated that the compound is stable in the presence of serum proteins, thiols, or disulfides and that it reacts with Cu(II) resulting in the formation of a Cu(I)DPPE complex. The results of these in vivo and in vitro experiments suggest that the contrasting pharmacological profile of [Au(DPPE)2]Cl with respect to other gold(I) phosphine complexes may be related to both the kinetic stability of the complex and its stability in the presence of thiols. |
| | |
Authors:
|
S J Berners-Price; C K Mirabelli; R K Johnson; M R Mattern; F L McCabe; L F Faucette; C M Sung; S M Mong; P J Sadler; S T Crooke |
Related Documents
:
|
21632277 - Vibrational spectra of double oxalates of the type m(i)(2)cu(c(2)o(4))(2)·2h(2)o (m(i)... 16923597 - Enhanced photocatalysis of pentachlorophenol by metal-modified titanium (iv) oxide. 18507457 - Structural and spectroscopic impact of tuning the stereochemical activity of the lone p... 16539447 - Structural transformation of au-pd bimetallic nanoclusters on thermal heating and cooli... 19594157 - Vibrational modes of the vinyl and deuterated vinyl radicals. 11669967 - Copper(ii) complexes of bis(1,4,7-triazacyclononane) ligands with polymethylene bridgin... |
Publication Detail:
|
Type: Journal Article; Research Support, Non-U.S. Gov't |
Journal Detail:
|
Title: Cancer research Volume: 46 ISSN: 0008-5472 ISO Abbreviation: Cancer Res. Publication Date: 1986 Nov |
Date Detail:
|
Created Date: 1986-11-20 Completed Date: 1986-11-20 Revised Date: 2008-11-21 |
Medline Journal Info:
|
Nlm Unique ID: 2984705R Medline TA: Cancer Res Country: UNITED STATES |
Other Details:
|
Languages: eng Pagination: 5486-93 Citation Subset: IM |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Animals Antineoplastic Agents* Cell Survival / drug effects Chemical Phenomena Chemistry Cisplatin / administration & dosage Copper Copper Sulfate DNA / drug effects Gold / therapeutic use* Leukemia L1210 / drug therapy Leukemia P388 / drug therapy* Leukemia, Experimental / drug therapy* Magnetic Resonance Spectroscopy Melanoma, Experimental / drug therapy Mice Nucleic Acids / biosynthesis Organogold Compounds Organometallic Compounds* Organophosphorus Compounds / therapeutic use* Protein Biosynthesis Sarcoma, Experimental / drug therapy* |
| Chemical | |
Reg. No./Substance:
|
0/Antineoplastic Agents; 0/Nucleic Acids; 0/Organogold Compounds; 0/Organometallic Compounds; 0/Organophosphorus Compounds; 15663-27-1/Cisplatin; 47895-18-1/bis(1,2-bis(diphenylphosphino)ethane)gold(I); 7440-50-8/Copper; 7440-57-5/Gold; 7758-98-7/Copper Sulfate; 9007-49-2/DNA |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Selenium-induced cytotoxicity of human leukemia cells: interaction with reduced glutathione.
Next Document: Sympathetic nervous system trophism for neuroblastoma and its age dependence in rats.